Ignite Creation Date:
2024-05-05 @ 4:59 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363090
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2006-08-10
Brief Title:
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II Stage III or Stage IV T-Cell Non-Hodgkins Lymphoma
Sponsor:
Toronto Sunnybrook Regional Cancer Centre
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| stage IV adult T-cell leukemialymphoma | View |
| contiguous stage II adult diffuse large cell lymphoma | View |
| contiguous stage II adult diffuse mixed cell lymphoma | View |
| noncontiguous stage II adult diffuse large cell lymphoma | View |
| noncontiguous stage II adult diffuse mixed cell lymphoma | View |
| stage III adult diffuse large cell lymphoma | View |
| stage III adult diffuse mixed cell lymphoma | View |
| stage IV adult diffuse large cell lymphoma | View |
| stage IV adult diffuse mixed cell lymphoma | View |
| angioimmunoblastic T-cell lymphoma | View |
| anaplastic large cell lymphoma | View |
| stage II adult T-cell leukemialymphoma | View |
| stage III adult T-cell leukemialymphoma | View |